Recent insights on the mechanisms of liver preconditioning

被引:164
作者
Carini, R [1 ]
Albano, E [1 ]
机构
[1] Univ A Avogadro E Piemonte, Dept Med Sci, I-28100 Novara, Italy
关键词
D O I
10.1016/j.gastro.2003.05.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Ischemia/reperfusion is the main cause of hepatic damage consequent to temporary clamping of the hepatoduodenal ligament during liver surgery as well as graft failure after liver transplantation. In recent years, a number of animal studies have shown that pre-exposure of the liver to transient ischemia, hyperthermia, or mild oxidative stress increases the tolerance to reperfusion injury, a phenomenon known as hepatic preconditioning. The development of hepatic preconditioning can be differentiated into 2 phases. An immediate phase (early preconditioning) occurs within minutes and involves the direct modulation of energy supplies, pH regulation, Na+ and Ca2+ homeostasis, and caspase activation. The subsequent phase (late preconditioning) begins :12-24 hours after the stimulus and requires the synthesis of multiple stress-response proteins, including heat shock proteins HSP70, HSP27, and HSP32/heme oxygenase 1. Hepatic preconditioning is not limited to parenchymal cells but ameliorates sinusoidal perfusion, prevents postischemic neutrophil infiltration, and decreases the production of proinflammatory cytokines by Kupffer cells. This latter effect is important in improving systemic disorders associated with hepatic ischemia/reperfusion. The signals triggering hepatic preconditioning have been partially characterized, showing that adenosine, nitric oxide, and reactive oxygen species can activate multiple protein kinase cascades involving, among others, protein kinase C and p38 mitogen-activated protein kinase. These observations, along with preliminary studies in humans, give a rationale to perform clinical trials aimed at verifying the possible application of hepatic preconditioning in preventing ischemia/reperfusion injury during liver surgery.
引用
收藏
页码:1480 / 1491
页数:12
相关论文
共 108 条
[81]  
Ralevic V, 1998, PHARMACOL REV, V50, P413
[82]   Extended preservation of rat liver graft by induction of heme oxygenase-1 [J].
Redaelli, CA ;
Tian, YH ;
Schaffner, T ;
Ledermann, M ;
Baer, HU ;
Dufour, JF .
HEPATOLOGY, 2002, 35 (05) :1082-1092
[83]   Mechanisms of pH preservation during global ischemia in preconditioned rat heart: roles for PKC and NHE [J].
Rehring, TF ;
Shapiro, JI ;
Cain, BS ;
Meldrum, DR ;
Cleveland, JC ;
Harken, AH ;
Banerjee, A .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1998, 275 (03) :H805-H813
[84]   SUPPRESSION OF LIPOPOLYSACCHARIDE-STIMULATED RELEASE OF TUMOR-NECROSIS-FACTOR BY ADENOSINE - EVIDENCE FOR A(2) RECEPTORS ON RAT KUPFFER CELLS [J].
REINSTEIN, LJ ;
LICHTMAN, SN ;
CURRIN, RT ;
WANG, J ;
THURMAN, RG ;
LEMASTERS, JL .
HEPATOLOGY, 1994, 19 (06) :1445-1452
[85]   Protein kinase C inhibition abrogates hepatic ischemic preconditioning responses [J].
Ricciardi, R ;
Meyers, WC ;
Schaffer, BK ;
Kim, RD ;
Shah, SA ;
Wheeler, SM ;
Donohue, SE ;
Sheth, KR ;
Callery, MP ;
Chari, RS .
JOURNAL OF SURGICAL RESEARCH, 2001, 97 (02) :144-149
[86]   LIVER-CELL NECROSIS - CELLULAR MECHANISMS AND CLINICAL IMPLICATIONS [J].
ROSSER, BG ;
GORES, GJ .
GASTROENTEROLOGY, 1995, 108 (01) :252-275
[87]   Atrial natriuretic peptide mimetics and vasopeptidase inhibitors [J].
Sagnella, GA .
CARDIOVASCULAR RESEARCH, 2001, 51 (03) :416-428
[88]   Induction of cellular resistance against Kupffer cell-derived oxidant stress: A novel concept of hepatoprotection by ischemic preconditioning [J].
Schauer, RJ ;
Gerbes, AL ;
Vonier, D ;
op den Winkel, M ;
Fraunberger, P ;
Bilzer, M .
HEPATOLOGY, 2003, 37 (02) :286-295
[89]   Signal transduction of ischemic preconditioning [J].
Schulz, R ;
Cohen, MV ;
Behrends, M ;
Downey, JM ;
Heusch, G .
CARDIOVASCULAR RESEARCH, 2001, 52 (02) :181-198
[90]   Fatty liver in liver transplantation and surgery [J].
Selzner, M ;
Clavien, PA .
SEMINARS IN LIVER DISEASE, 2001, 21 (01) :105-113